Category - Executive Moves

Executive Moves

Can-Fite CEO to chair cancer conference session

Dr. Pnina Fishman, CEO of Can-Fite BioPharma (NYSE MKT:CANF; TASE:CFBI) will chair the plenary session titled, “Drugs Targeting Adenosine Receptors,” at the 2016 Keystone Symposia J5 in Vancouver, Canada on Jan. 24-28...

January 25, 2016

Executive Moves

Galectin appoints Dr. Marc Rubin as chairman

Galectin Therapeutics (NASDAQ:GALT) has announced the election of Dr. Marc Rubin as chairman, succeeding James Czirr, who helped found the company in 2000. Mr. Czirr will continue as a director.Dr. Rubin is a leading...

January 8, 2016

Executive Moves

Carol Werther joins HCW as senior biotech analyst

Carol Ann Werther has joined H.C. Wainwright as a managing director and senior biotechnology analyst in the firm’s equity research group.Ms. Werther joins HCW with over 20 years of experience in the biotechnology sector...

December 3, 2015

Category - Executive Moves

Can-Fite CEO to chair cancer conference session

Galectin appoints Dr. Marc Rubin as chairman

Carol Werther joins HCW as senior biotech analyst

General

More